Corporate insiders and private money
Samuelson Doug
- SEC filer ID (CIK)
- 1943326 EDGAR ↗
| Filed | Form | Company | Role | Sold | Bought | Filing |
|---|---|---|---|---|---|---|
| 2025-11-26 | 4 | Kairos Pharma, LTD. KAPA | Officer Chief Financial Officer | EDGAR ↗ | ||
| 2024-11-25 | 4 | Kairos Pharma, LTD. KAPA | Officer Chief Financial Officer | $3,750 | EDGAR ↗ | |
| 2024-09-24 | 3 | Kairos Pharma, LTD. KAPA | Officer Chief Financial Officer | EDGAR ↗ | ||
| 2024-09-12 | 4 | Sacks Parente Golf, Inc. SPGC | Officer Chief Financial Officer | EDGAR ↗ | ||
| 2024-09-12 | 3 | Sacks Parente Golf, Inc. SPGC | Officer Chief Financial Officer | EDGAR ↗ | ||
| 2023-09-12 | 4 | GENELUX Corp GNLX | Officer Vice President, Finance | EDGAR ↗ | ||
| 2023-08-22 | 4 | GENELUX Corp GNLX | Officer Chief Financial Officer | $30,777 | EDGAR ↗ | |
| 2023-05-02 | 4 | GENELUX CORP GNLX | Officer Chief Financial Officer | EDGAR ↗ | ||
| 2023-01-25 | 3 | GENELUX CORP GNLX | Officer Chief Financial Officer | EDGAR ↗ |
Sold and Bought: shares times price for open-market sales and purchases on that filing.
Insider trades
| Company | Sold | Bought | Trades | Dates |
|---|---|---|---|---|
| GENELUX Corp | $30,777 | 1 | 2023-08-18 | |
| Kairos Pharma, LTD. | $3,750 | 1 | 2024-11-22 |
| Date | Company | Trade | Shares | Price | Total | Notes | Filing |
|---|---|---|---|---|---|---|---|
| 2024-11-22 | Kairos Pharma, LTD. KAPA | Purchase | 2,500 | $1.50 | $3,750 | Form 4 ↗ | |
| 2023-08-18 | GENELUX Corp GNLX | Sale | 1,297 | $23.73 | $30,777 | Form 4 ↗ |
Open-market sales (code S) and purchases (code P) reported on Form 4, at the reported price. 10b5-1 plan: the filing says the trades were made under a prearranged trading plan (the Form 4 checkbox from 2023, or a footnote).